Next Vial vs NovoCare Pharmacy
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Next Vial
Best for: people seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner
Visit Next Vial →
NovoCare Pharmacy
Best for: branded Wegovy at the lowest manufacturer-direct self-pay price
Visit NovoCare Pharmacy →Next Vial and NovoCare Pharmacy are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, NovoCare Pharmacy starts lower at $149/mo versus $249.97/mo, and NovoCare Pharmacy edges ahead overall (8.7 vs 7.1 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.
Pricing
Next Vial
Starting monthly rate for GLP-1 program; tirzepatide rate not published.
NovoCare Pharmacy
$149/mo for 1.5 mg and 4 mg new self-pay; 4 mg offer ends 8/31/2026, then $199/mo for 4 mg
$199/mo intro = first 2 monthly fills (0.25/0.5 mg) for patients new to the offer/pharmacy, through 6/30/2026; then $349/mo standard
with commercial insurance, as little as $25/mo; subject to max savings of $100/month
What’s included
Next Vial
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
NovoCare Pharmacy
Inclusions not disclosed.
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Next Vial
7.1/10
NovoCare Pharmacy
8.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Next Vial | NovoCare Pharmacy |
|---|---|---|
| Starting Price | $249.97/mo | ✓$149/mo |
| Features | ✓7 features | 5 features |
| States Available | 49 | ✓50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About Next Vial
Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options. LegitScript verified with medication dispensed through Manifest Pharmacy (Greer, SC). No membership required — one transparent price covering consultation, medication, and free shipping. Serves 49 states.
Read our full Next Vial review →About NovoCare Pharmacy
Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide). Manufacturer-owned channel: Wegovy 0.25 mg / 0.5 mg starter doses at $199/month through 6/30/2026; full-dose Wegovy at $349/month standard self-pay; Wegovy HD at $399/month. Ships nationwide. Distinct from telehealth platforms that route Wegovy through NovoCare — this is the manufacturer pharmacy itself.
Read our full NovoCare Pharmacy review →Pros & Cons
Next Vial
What we like
- LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
- No membership fees — one all-in price covering consultation, medication, and shipping
- Compounded semaglutide, tirzepatide, and microdose options available
- Free rushed shipping; serves 49 states nationwide
- Board-certified physician oversight with ongoing provider support
Watch-outs
- Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
- Compounded medications are not FDA-approved
- Labs and nutritional coaching not disclosed
- Microdose pricing not published on product page
- Alaska not listed among served states
NovoCare Pharmacy
What we like
- First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
- $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
- $349/mo standard self-pay is well below the ~$1,300/mo retail list price
- Ships to all 50 states with no telehealth-platform middleman fees
- Cold-chain logistics handled directly by Novo Nordisk
- Insurance-billing path available via the NovoCare savings program
- NEW $149/mo Wegovy pill (oral semaglutide tablets, 1.5/4 mg) self-pay tier — 4 mg rises to $199/mo after 8/31/2026
Watch-outs
- Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
- Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
- No clinical support included — your own prescriber handles titration and side effects
- Manufacturer-set pricing can change at any time
- $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)
Our Verdict
NovoCare Pharmacy edges out Next Vial with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Next Vial remains a solid alternative, especially if you're looking for people seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
Choose Next Vial if…
You want people seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner and a starting price around $249.97/mo.
Choose NovoCare Pharmacy if…
You want branded Wegovy at the lowest manufacturer-direct self-pay price and a starting price around $149/mo.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online, ranked by our editorial score.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Embody
Lowest first-month entry pricing on compounded GLP-1s
From $99/mo
Get started →TrimRx
Best overall value
From $179/mo
Get started →Telos Rx
Needle-free and microdosed compounded GLP-1 options with lab-monitored care
From $49/mo
Get started →Next Vial vs NovoCare Pharmacy: FAQ
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Next Vial and NovoCare Pharmacy head-to-heads in the same category.
- Next Vial vs CoreAge Rx
- Next Vial vs Amazon One Medical
- Next Vial vs Vytora Health
- NovoCare Pharmacy vs Enhance MD
- NovoCare Pharmacy vs Noom Med
- NovoCare Pharmacy vs Novi
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.